Carlyle Group Adjusts QuidelOrtho Stake
Ticker: QDEL · Form: SC 13D/A · Filed: Aug 5, 2024 · CIK: 1906324
| Field | Detail |
|---|---|
| Company | Quidelortho Corp (QDEL) |
| Form Type | SC 13D/A |
| Filed Date | Aug 5, 2024 |
| Risk Level | medium |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.001, $38.88, $40.09, $39.7442, $38.25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, investment-firm
Related Tickers: QDEL
TL;DR
Carlyle Group filed a 13D/A for QuidelOrtho, looks like they adjusted their holdings.
AI Summary
Carlyle Group Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of QuidelOrtho Corp. as of August 5, 2024. The filing details the group members involved in this ownership, including various Carlyle Holdings and TC Group entities. This amendment likely reflects adjustments to their investment or control stake in QuidelOrtho.
Why It Matters
This filing signals potential shifts in major shareholder influence or strategy for QuidelOrtho Corp., a company in the diagnostic substances sector.
Risk Assessment
Risk Level: medium — Changes in beneficial ownership by a large investment firm like Carlyle can signal strategic shifts or potential future actions impacting the company's stock.
Key Players & Entities
- Carlyle Group Inc. (company) — Filing entity
- QuidelOrtho Corp (company) — Subject company
- CARLYLE HOLDINGS II GP L.L.C. (company) — Group member
- CARLYLE HOLDINGS II L.L.C. (company) — Group member
- CARLYLE PARTNERS VI CAYMAN HOLDINGS, L.P. (company) — Group member
- CG SUBSIDIARY HOLDINGS L.L.C. (company) — Group member
- TC GROUP CAYMAN INVESTMENT HOLDINGS SUB L.P. (company) — Group member
- TC GROUP CAYMAN INVESTMENT HOLDINGS, L.P. (company) — Group member
- TC GROUP VI CAYMAN, L.L.C. (company) — Group member
- TC GROUP VI CAYMAN, L.P. (company) — Group member
FAQ
What specific change in beneficial ownership is reported in this SC 13D/A filing for QuidelOrtho Corp?
The filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership, but the specific percentage or number of shares acquired or disposed of is not detailed in the provided header information.
Who are the primary entities filing this amendment regarding QuidelOrtho Corp?
Carlyle Group Inc. and its various group members, including Carlyle Holdings II GP L.L.C. and TC Group entities, are filing the amendment.
What is the business address of QuidelOrtho Corp?
The business address for QuidelOrtho Corp is 9975 Summers Ridge Road, San Diego, CA 92121.
When was QuidelOrtho Corp formerly known as?
QuidelOrtho Corp was formerly known as Coronado Topco, Inc., with a name change effective January 24, 2022.
What is the SIC code for QuidelOrtho Corp?
The Standard Industrial Classification (SIC) code for QuidelOrtho Corp is 2835, which pertains to In Vitro & In Vivo Diagnostic Substances.
Filing Stats: 2,456 words · 10 min read · ~8 pages · Grade level 8.2 · Accepted 2024-08-05 16:30:31
Key Financial Figures
- $0.001 — relating to the common stock, par value $0.001 per share (the “Common Stock&rdqu
- $38.88 — e Per Share July 30, 2024 150,590 $38.88 to $40.09 $39.7442 July 31, 2024
- $40.09 — e July 30, 2024 150,590 $38.88 to $40.09 $39.7442 July 31, 2024 164,877
- $39.7442 — 30, 2024 150,590 $38.88 to $40.09 $39.7442 July 31, 2024 164,877 $38.25 to $
- $38.25 — $39.7442 July 31, 2024 164,877 $38.25 to $39.80 $39.1065 August 1, 2024
- $39.80 — 2 July 31, 2024 164,877 $38.25 to $39.80 $39.1065 August 1, 2024 234,935
- $39.1065 — 31, 2024 164,877 $38.25 to $39.80 $39.1065 August 1, 2024 234,935 $39.83 to
- $39.83 — $39.1065 August 1, 2024 234,935 $39.83 to $42.52 $41.5156 August 2, 2024
- $42.52 — August 1, 2024 234,935 $39.83 to $42.52 $41.5156 August 2, 2024 169,467
- $41.5156 — 1, 2024 234,935 $39.83 to $42.52 $41.5156 August 2, 2024 169,467 $39.96 to
- $39.96 — $41.5156 August 2, 2024 169,467 $39.96 to $43.0003 $42.1015 (d) None. (e
- $43.0003 — August 2, 2024 169,467 $39.96 to $43.0003 $42.1015 (d) None. (e) Not appli
- $42.1015 — , 2024 169,467 $39.96 to $43.0003 $42.1015 (d) None. (e) Not applicable. CU
Filing Documents
- formsc13da.htm (SC 13D/A) — 272KB
- 0001493152-24-030259.txt ( ) — 274KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : August 5, 2024 The Carlyle Group Inc. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Chief Financial Officer Carlyle Holdings II GP L.L.C. By: The Carlyle Group Inc., its sole member By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Chief Financial Officer Carlyle Holdings II L.L.C. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director CG Subsidiary Holdings L.L.C. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group Cayman Investment Holdings, L.P. By: CG Subsidiary Holdings L.L.C., its general partner By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group Cayman Investment Holdings Sub L.P. By: TC Group Cayman Investment Holdings, L.P., its general partner By: CG Subsidiary Holdings L.L.C., its general partner By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group VI Cayman, L.L.C. By: /s/ Robert Rosen Name: Robert Rosen Title: Vice President TC Group VI Cayman, L.P. By: TC Group VI Cayman, L.L.C., its general partner By: /s/ Robert Rosen Name: Robert Rosen Title: Vice President Carlyle Partners VI Cayman Holdings, L.P. By: TC Group VI Cayman, L.P., its general partner By: TC Group VI Cayman, L.L.C., its general partner By: /s/ Robert Rosen Name: Robert Rosen Title: Vice President